全文获取类型
收费全文 | 15764篇 |
免费 | 1168篇 |
国内免费 | 478篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 262篇 |
妇产科学 | 256篇 |
基础医学 | 1317篇 |
口腔科学 | 552篇 |
临床医学 | 2047篇 |
内科学 | 2677篇 |
皮肤病学 | 254篇 |
神经病学 | 797篇 |
特种医学 | 323篇 |
外国民族医学 | 1篇 |
外科学 | 1595篇 |
综合类 | 1848篇 |
现状与发展 | 3篇 |
预防医学 | 779篇 |
眼科学 | 112篇 |
药学 | 3497篇 |
6篇 | |
中国医学 | 570篇 |
肿瘤学 | 407篇 |
出版年
2023年 | 275篇 |
2022年 | 283篇 |
2021年 | 759篇 |
2020年 | 593篇 |
2019年 | 512篇 |
2018年 | 477篇 |
2017年 | 458篇 |
2016年 | 418篇 |
2015年 | 510篇 |
2014年 | 802篇 |
2013年 | 1076篇 |
2012年 | 790篇 |
2011年 | 925篇 |
2010年 | 691篇 |
2009年 | 606篇 |
2008年 | 623篇 |
2007年 | 683篇 |
2006年 | 563篇 |
2005年 | 475篇 |
2004年 | 464篇 |
2003年 | 397篇 |
2002年 | 333篇 |
2001年 | 288篇 |
2000年 | 269篇 |
1999年 | 217篇 |
1998年 | 188篇 |
1997年 | 194篇 |
1996年 | 182篇 |
1995年 | 219篇 |
1994年 | 205篇 |
1993年 | 188篇 |
1992年 | 174篇 |
1991年 | 184篇 |
1990年 | 204篇 |
1989年 | 176篇 |
1988年 | 147篇 |
1987年 | 154篇 |
1986年 | 155篇 |
1985年 | 202篇 |
1984年 | 188篇 |
1983年 | 137篇 |
1982年 | 202篇 |
1981年 | 130篇 |
1980年 | 134篇 |
1979年 | 97篇 |
1978年 | 75篇 |
1977年 | 91篇 |
1976年 | 72篇 |
1975年 | 63篇 |
1974年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
61.
《The Journal of arthroplasty》2020,35(2):325-330
BackgroundTo investigate the effects of platelet-rich plasma (PRP)-incorporated autologous granular bone grafts for treatment in the precollapse stages (Association of Research Circulation Osseous stage II–III) of posttraumatic osteonecrosis of the femoral head.MethodsA total of 46 patients were eligible and enrolled in the study. Twenty-four patients were treated with core decompression and PRP-incorporated autologous granular bone grafting (treatment group), and 22 patients were treated with core decompression and autologous granular bone grafting (control group). During a minimum follow-up duration of 36 months, X-ray and computed tomography were used to evaluate the radiological results, and the Harris hip score (HHS) and visual analog scale were chosen to assess the clinical results.ResultsBoth the treatment and control groups had a significantly improved HHS (P < .001). The minimum clinically important difference for the HHS was reached in 91.7% of the treatment group and 68.2% of the control group (P < .05). The HHS and visual analog scale in the treatment group were significantly improved than that in the control group at the last follow-up (P < .05). Successful clinical and radiological results were achieved 87.5% and 79.2% in the treatment group compared with 59.1% and 50.0% in the control group (P < .05), respectively. The survival rates based on the requirement for further hip surgery as an endpoint were higher in the treatment group in comparison to those in the control group (P < .05).ConclusionPRP-incorporated autologous granular bone grafting is a safe and effective procedure for treatment in the precollapse stages (Association of Research Circulation Osseous stage II–III) of posttraumatic osteonecrosis of the femoral head. 相似文献
62.
目的:探究超脉冲CO2点阵激光联合富血小板血浆(PRP)治疗面部痤疮凹陷性瘢痕的疗效。方法:72例面部痤疮凹陷性瘢痕患者,随机分为观察组(36例)和对照组(36例)。对照组采用超脉冲CO2点阵激光治疗,观察组采用超脉冲CO2点阵激光联合PRP治疗。比较两组患者的灰度差异、时间指标、瘢痕程度、疼痛、不良反应及视觉评估。结果:观察组的并发症发生率为11.11%,低于对照组的36.11%,差异具有统计学意义(P<0.05)。治疗后,两组患者的灰度差异率均减小,且观察组患者的灰度差异率显著低于对照组,差异具有统计学意义(P<0.05)。治疗后,观察组的炎性渗出时间、红肿时间、愈合时间、停工时间及瘢痕程度评分均低于对照组,差异均具有统计学意义(P<0.05);但疼痛度评分组间比较,差异无统计学意义(P>0.05)。结论:超脉冲CO2点阵激光联合PRP治疗面部痤疮凹陷性瘢痕效果较好,可有效降低瘢痕程度,减少治疗时间及并发症的发生,帮助患者迅速回归正常工作与生活,值得临床推广使用。 相似文献
63.
64.
Pierre Tiberghien Xavier de Lamballerie Pascal Morel Pierre Gallian Karine Lacombe Yazdan Yazdanpanah 《Vox sanguinis》2020,115(6):488-494
Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number of COVID-19 cases escalates steeply worldwide. Prior findings in various viral respiratory diseases including SARS-CoV-related pneumonia suggest that convalescent plasma can reduce mortality, although formal proof of efficacy is still lacking. By reducing viral spread early on, such an approach may possibly downplay subsequent immunopathology. Identifying, collecting, qualifying and preparing plasma from convalescent patients with adequate SARS-CoV-2-neutralizing Ab titres in an acute crisis setting may be challenging, although well within the remit of most blood establishments. Careful clinical evaluation should allow to quickly establish whether such passive immunotherapy, administered at early phases of the disease in patients at high risk of deleterious evolution, may reduce the frequency of patient deterioration, and thereby COVID-19 mortality. 相似文献
65.
Daniel J. Robbins Natalie E. Taylor Damodaran Narayanan Aaron S. Hess William N. Rose 《Journal of clinical apheresis》2020,35(2):128-130
A 32-year-old male with type I diabetes presented with profound hypoglycemia due to exogenous insulin antibody syndrome in the setting of newly-diagnosed common variable immunodeficiency. Immunomodulatory therapy was not initially effective, but after the initiation of plasma exchange hypoglycemia resolved, and glucose lability improved. 相似文献
66.
Alessandro Salvalaggio Annachiara Cagnin Piero Marson Franco Ferracci Pietro Cortelli Maurizio Corbetta Chiara Briani 《Journal of clinical apheresis》2020,35(3):231-233
Around half of the patients with Guillain-Barré syndrome (GBS) present autonomic dysfunction requiring admission to intensive care unit in up to a quarter of patients. Treatment of GBS consists of plasma exchange (PE) and intravenous immunoglobulins (IVIG). Posterior reversible encephalopathy syndrome (PRES) consists in a reversible subcortical vasogenic brain edema caused by endothelial damage triggered by abrupt blood pressure changes. We report on a woman who presented with PRES in the course of GBS treated first with IVIG, and then with PE. The present report underlines the challenge that the clinicians face when these two rare syndromes concur. The literature is not helpful considering that both blood pressure fluctuations and IVIG are reported to be involved in the pathogenesis of PRES. In the present letter, both pathogenic mechanisms and clinical management considerations are discussed. 相似文献
67.
68.
Deepti Upadhyay Alka Singh Prasenjit Das Jiya Mehtab Siddhartha Dattagupta Vineet Ahuja Govind K. Makharia Naranamangalam R. Jagannathan Uma Sharma 《NMR in biomedicine》2020,33(8)
Celiac disease (CeD) is an autoimmune enteropathy caused by gluten intake in genetically predisposed individuals. We investigated the metabolism of CeD by metabolic profiling of intestinal mucosa, blood plasma and urine using NMR spectroscopy and multivariate analysis. The metabolic profile of the small intestinal mucosa was compared between patients with CeD (n = 64) and disease controls (DCs, n = 30). The blood plasma and urinary metabolomes of CeD patients were compared with healthy controls (HCs, n = 39). Twelve metabolites (proline (Pro), arginine (Arg), glycine (Gly), histidine (His), glutamate (Glu), aspartate, tryptophan (Trp), fumarate, formate, succinate (Succ), glycerophosphocholine (GPC) and allantoin (Alln)) of intestinal mucosa differentiated CeD from controls. The metabolome of blood plasma with 18 metabolites (Pro, Arg, Gly, alanine, Glu, glutamine, glucose (Glc), lactate (Lac), acetate (Ace), acetoacetate (AcAc), β‐hydroxybutyrate (β‐OHB), pyruvate (Pyr), Succ, citrate (Cit), choline (Cho), creatine (Cr), phosphocreatine (PCr) and creatinine) and 9 metabolites of urine (Pro, Trp, β‐OHB, Pyr, Succ, N‐methylnicotinamide (NMN), aminohippurate (AHA), indoxyl sulfate (IS) and Alln) distinguished CeD from HCs. Our data demonstrated changes in nine metabolic pathways. The altered metabolites were associated with increased oxidative stress (Alln), impaired healing and repair mechanisms (Pro, Arg), compromised anti‐inflammatory and cytoprotective processes (Gly, His, NMN), altered energy metabolism (Glc, Lac, β‐OHB, Ace, AcAc, Pyr, Succ, Cit, Cho, Cr and PCr), impaired membrane metabolism (GPC and Cho) and intestinal dysbiosis (AHA and IS). An orthogonal partial least square discriminant analysis model provided clear differentiation between patients with CeD and controls in all three specimens. A classification model built by combining the distinguishing metabolites of blood plasma and urine samples gave an AUC of 0.99 with 97.7% sensitivity, 93.3% specificity and a predictive accuracy of 95.1%, which was higher than for the models built separately using small intestinal mucosa, blood plasma and urine. In conclusion, a panel of metabolic biomarkers in intestinal biopsies, plasma and urine samples has potential to differentiate CeD from controls and may complement traditional tests to improve the diagnosis of CeD. 相似文献
69.
70.
《Anaesthesia and Intensive Care Medicine》2022,23(5):304-311
Understanding the physiology of fluid distribution in the human body is fundamental to good clinical practice in anaesthesia and intensive care. Intravenous fluid therapies have a range of clinical and metabolic consequences, and they should be context and patient specific. Inadequate or excessive fluid treatment is harmful to patients. There are numerous trials, both historical and current, investigating best practice in fluid therapy. New paradigms and guidelines are being published, and it is important for clinicians to keep up to date with current practice. There is also a continued drive to improve the safety of donor blood products and prevent transfusion errors. Knowledge of how blood products are collected, separated, stored and administered is essential to prevent harm to patients through transfusions. The development of blood substitutes is progressing, and multinational trials are ongoing. 相似文献